Meag Munich Ergo’s Incyte INCY Stock Holding History

Meag Munich Ergo’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,598	Closed	-$229K	–	355
2019 Q4	$229K	Sell	2,598 -9,486	-79%	-$810K	0.02%	400
2019 Q3	$876K	Buy	12,084 +5,824	+93%	+$471K	0.05%	385
2019 Q2	$531K	Hold	6,260	–	–	0.04%	388
2019 Q1	$536K	Buy	+6,260	New	+$509K	0.04%	383
2018 Q1	–	Sell	-8,177	Closed	-$784K	–	446
2017 Q4	$784K	Buy	+8,177	New	+$855K	0.03%	385

Other funds holding INCY

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Meag Munich Ergo's INCY Position: Q1 2020 in Review

Meag Munich Ergo sold out of Incyte (INCY) in Q1 2020, closing a stake of 2,598 shares — an estimated $229K sold.

Meag Munich Ergo first reported a position in INCY in Q4 2017 and held it in 5 quarters. The position peaked at $876K in Q3 2019. 491 funds tracked by Wall St. Rank hold INCY as of Q1 2020.

Meag Munich Ergo reported no remaining Incyte position as of Q1 2020 after selling out during the quarter.
Meag Munich Ergo sold 2,598 Incyte shares in Q1 2020, an estimated $229K.
Meag Munich Ergo first reported a position in Incyte in Q4 2017 and held it in 5 quarters.
Meag Munich Ergo's Incyte position peaked at $876K in Q3 2019.
491 funds tracked by Wall St. Rank held Incyte as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.